The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Primary IgA Nephropathy
Related studies linked through entity extraction aliases.
Related studies linked through entity extraction aliases.